Patents by Inventor Dana Lasko

Dana Lasko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090285833
    Abstract: Pharmaceutical compositions, each consisting of a cell-permeable fusion protein conjugate of a polypeptidic cell-membrane transport moiety and a Clostridium botulinum C3 exotransferase unit, or a functional analog thereof, are provided. The compositions are useful to prevent or inhibit uncontrolled proliferation, spreading, and migration of a metastatic neoplastic cell of a cancer in a mammal. The compositions can each effect or arrest combination of two or more of tumor cell proliferation, migration, angiogenesis, and metalloproteinase secretion.
    Type: Application
    Filed: March 11, 2009
    Publication date: November 19, 2009
    Applicant: BIOAXONE THERAPEUTIQUE INC.
    Inventors: Lisa McKerracher, Dana Lasko
  • Publication number: 20090142325
    Abstract: There is provided a method of prevention or inhibition of uncontrolled proliferation of a cancer comprising administration to a mammal of a therapeutically effective amount of a pharmaceutical composition comprising a cell-permeable fusion protein conjugate comprising a polypeptidic cell-membrane transport moiety and a Clostridium botulinum C3 exotransferase unit or a functional analog thereof.
    Type: Application
    Filed: December 8, 2008
    Publication date: June 4, 2009
    Inventors: Dana LASKO, Lisa McKerracher
  • Patent number: 7442686
    Abstract: The Rho family GTPases regulates axon growth and regeneration. Inactivation of Rho with C3, a toxin from Clostridium botulinum, can stimulate regeneration and sprouting of injured axons. The present invention provides novel chimeric C3-like Rho antagonists. The invention further provides evidence that these compounds promote repair when applied to the injured mammalian central nervous system, such as the retina. The present invention provide agents which are able to diffuse readily and therefore can promote repair for neurodegenerative disease of the eye, such as macular degeneration. The present invention further provides methods of treating macular degeneration, methods of inhibiting or reducing the rate of subretinal neovascularization and proliferation of neovascular tissue and methods of protecting retinal photoreceptor cell death.
    Type: Grant
    Filed: August 2, 2004
    Date of Patent: October 28, 2008
    Assignee: Bioaxone Therapeutique Inc.
    Inventors: Dana Lasko, Lisa McKerracher
  • Publication number: 20060134140
    Abstract: Pharmaceutical compositions, each consisting of a cell-permeable fusion protein conjugate of a polypeptidic cell-membrane transport moiety and a Clostridium botulinum C3 exotransferase unit, or a functional analog thereof, are provided. The compositions are useful to prevent or inhibit uncontrolled proliferation, spreading, and migration of a metastatic neoplastic cell of a cancer in a mammal. The compositions can each effect or arrest combination of two or more of tumor cell proliferation, migration, angiogenesis, and metalloproteinase secretion.
    Type: Application
    Filed: August 2, 2004
    Publication date: June 22, 2006
    Inventors: Dana Lasko, Lisa McKerracher
  • Publication number: 20050059595
    Abstract: The Rho family GTPases regulates axon growth and regeneration. Inactivation of Rho with C3, a toxin from Clostridium botulinum, can stimulate regeneration and sprouting of injured axons. The present invention provides novel chimeric C3-like Rho antagonists. These new antagonists are a significant improvement over C3 compounds because they are 3-4 orders of magnitude more potent to stimulate axon growth on inhibitory substrates than recombinant C3. The invention further provides evidence that these compounds promote repair when applied to the injured mammalian central nervous system.
    Type: Application
    Filed: August 2, 2004
    Publication date: March 17, 2005
    Inventors: Dana Lasko, Lisa McKerracher